Institutional investors purchased a net $1.2 million shares of TTNP during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 3.63% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 5.0 Thousand shares of Titan Pharmaceuticals Inc